Clinical trial NCT02234622: Comparing Effects of a Holistic Yoga Program and a Wellness Program on PTSD Symptoms
Official title: Outcomes of a Holistic Yoga Program Designed to Relieve PTSD (RELIEVE Trial)
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Stress Disorders, Post-Traumatic
Keywords: Stress Disorders, Post-Traumatic
Yoga
Veterans
Lead sponsor: VA Office of Research and Development
Sponsor class: FED
First posted: 2014-09-09
Enrollment: 212
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Given the limited effectiveness of current treatments and the burden PTSD places on Veterans, civilians and clinicians, this research aims to compare the effects of a standardized, traditional, holistic yoga intervention (postures, breathing, deep muscle contraction and relaxation practices) with a wellness program (wellness topics and physical activity) on PTSD symptoms.

Detailed description: Posttraumatic Stress Disorder constitutes a substantial proportion of the burden of illness among Veterans. However, current PTSD treatments are not effective for all, and a significant number remain symptomatic despite pharmacotherapy and psychotherapy. As a result, there has been increased interest within the military and VA in Complementary and Alternative Medicine approaches, such as yoga, to improve symptoms without requiring direct verbal processing of the trauma. Yoga provides an innovative approach to calming hyperarousal, reducing numbness/avoidance, and improving self-regulation of emotions, while cultivating physical and emotional well-being. Because of this unique approach to the biological, psychological, and social dimensions of PTSD, we believe that yoga interventions are poised to meet the demand for more effective PTSD treatment options for Veterans. Recent research indicates that yoga interventions can be delivered successfully to individuals who have PTSD and have the potential to reduce clinician rated and self-reported overall PTSD symptoms, depression and anxiety. However, few studies exist that have evaluated yoga for PTSD and they have involved small sample sizes and are either uncontrolled or waitlist/usual care controlled. Also, there is much variation among studies in the style and components of yoga interventions. Thus, a randomized controlled trial of a standardized, traditional, holistic yoga intervention is urgently needed to inform VA policy makers and clinicians of the potential benefits of yoga as an adjunct to currently available PTSD treatments.

OBJECTIVE: The overall goal of this project is to compare the effects of a 16-week Holistic Yoga Program (HYP) with a 16-week Wellness Lifestyle Program (WLP) on PTSD and related symptoms and outcomes. This project has three specific aims: 1) to compare the effects of the interventions (HYP vs. WLP) on overall PTSD symptom severity; 2) compare the interventions' effects on PTSD-specific symptoms (anger, sleep), PTSD-related symptoms (depression, anxiety, pain) and related outcomes (well-being/quality of life); 3) to manualize the Holistic Yoga Program and training process for experienced yoga teachers to deliver HYP to individuals who have PTSD in order to facilitate future study and dissemination efforts.

METHODS: This study sample will include 212 outpatients with a clinician-confirmed diagnosis of PTSD, recruited from the Roudebush VA Medical Center as well as metropolitan area mental health clinicians and military/Veterans' organizations, who will be randomly assigned to receive the Holistic Yoga Program (HYP) or the Wellness Lifestyle Program (WLP). The HYP will involve a standardized 16-week intervention consisting of: 1) in-person group yoga class taught by a yoga therapist (Yoga Alliance minimum 200 hour level) with trained assistants.Classes will include (1) yoga postures, breathing practices, deep muscle contraction practices, relaxation practices, and integration of scientific rational and yoga philosophy within the instruction; (2) video and audio recordings for home practice; and 4) a Participant Handbook to reinforce concepts taught during in-person sessions. The WLP is an attention control comprised of low intensity walking and didactics about wellness topics that will also encourage home practice and provide a Participant Handbook to reinforce concepts taught during in-person sessions.

Eligibility criteria: Inclusion Criteria:

Veterans and civilians will be eligible for inclusion if

* they are age 18 or older,
* have a Clinician Administered PTSD Scale-confirmed PTSD diagnosis,
* and access to a working telephone for ease of contact during the course of the study.

Exclusion Criteria:

Exclusion criteria will include:

* severe medical conditions in which yoga is contraindicated;
* active psychosis;
* active suicidal intent;
* moderate to severe cognitive impairment as determined by the short Mini-Mental State Examination, a six-item screener (MMSE);
* involvement in ongoing yoga classes and/or regular home practice of yoga in the previous 3 months;
* and receiving ongoing medical or psychological treatment that includes more than one hour weekly of relaxation and mind-body based stress reduction strategies (related directly to meditation and yoga).

Primary outcomes:
measure: Clinician Administered PTSD Scale (CAPS-5)
timeFrame: Change from baseline to 16 weeks (end of treatment)
measure: PTSD Checklist
timeFrame: Change from baseline to 16 weeks (end of treatment)
Secondary outcomes:
measure: Medical Outcomes Study 12-item Sleep Scale (MOS) Problem Index II
timeFrame: Change from baseline to 16 weeks (end of treatment)
measure: Patient Reported Outcome Measure Information System (PROMIS) - Short Form 5a
timeFrame: Change from baseline to 16 weeks (end of treatment)
measure: Beck Depression Inventory-II
timeFrame: Change from baseline to 16 weeks (end of treatment)
measure: Spielberger State-Trait Anxiety (STAI) - State Subscale
timeFrame: Change from baseline to 16 weeks (end of treatment)
measure: Brief Pain Inventory (BPI) Item #3
timeFrame: Change from baseline to 16 weeks (end of treatment)
Other outcomes:
Locations:
city: Indianapolis
country: United States
facility: Richard L. Roudebush VA Medical Center, Indianapolis, IN
state: Indiana
Study officials:
affiliation: Richard L. Roudebush VA Medical Center, Indianapolis, IN
name: Louanne W Davis, PsyD
role: PRINCIPAL_INVESTIGATOR
References: